Huang, Chao-Yuan <br/><br/>
Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Jul 2013 
 - 456-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2013.01.025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Hepatocellular--therapy<br/>Chemoradiotherapy--methods<br/>Cyclin D1--antagonists & inhibitors<br/>Humans<br/>Inhibitor of Apoptosis Proteins--antagonists & inhibitors<br/>Liver Neoplasms--therapy<br/>Myeloid Cell Leukemia Sequence 1 Protein<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>RNA Interference<br/>Radiation Tolerance--drug effects<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>Sorafenib<br/>Survivin